BE563714A - - Google Patents
Info
- Publication number
- BE563714A BE563714A BE563714DA BE563714A BE 563714 A BE563714 A BE 563714A BE 563714D A BE563714D A BE 563714DA BE 563714 A BE563714 A BE 563714A
- Authority
- BE
- Belgium
- Prior art keywords
- hormone
- extract
- purification
- mixture
- solvent
- Prior art date
Links
- 239000005556 hormone Substances 0.000 claims description 28
- 229940088597 hormone Drugs 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 235000013336 milk Nutrition 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 210000000481 breast Anatomy 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 5
- 230000008020 evaporation Effects 0.000 claims description 5
- 230000020477 pH reduction Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 235000014121 butter Nutrition 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000008939 whole milk Nutrition 0.000 description 3
- 206010001367 Adrenal insufficiency Diseases 0.000 description 2
- 230000001919 adrenal effect Effects 0.000 description 2
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- -1 alcohols and ketones Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE563714A true BE563714A (enrdf_load_stackoverflow) |
Family
ID=184845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE563714D BE563714A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE563714A (enrdf_load_stackoverflow) |
-
0
- BE BE563714D patent/BE563714A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1373176B1 (fr) | Extrait de coques de graines de lupin contenant du lupeol | |
| FR2552426A1 (fr) | Procede pour l'obtention de solutions aqueuses d'acide glyoxylique | |
| BE563714A (enrdf_load_stackoverflow) | ||
| CH642262A5 (en) | Method for preparing a protein hydrolysate | |
| FR2589149A1 (fr) | Procede de separation et de purification de l'acide salicylique par precipitation a partir d'une solution aqueuse de son sel sodique | |
| CH374145A (fr) | Procédé de préparation d'un produit hormonal | |
| FR2472557A1 (fr) | Procede de resolution de l'acide d,1-2-(6-methoxy-2-naphtyl)-propionique et son application a un melange de sels des formes d et l de cet acide avec une n-alkyl-d-glucamine | |
| EP0012640A1 (fr) | Procédé de purification de l'acide chénodésoxycholique et produits obtenus par ce procédé | |
| CH646181A5 (fr) | Procede de purification de l'acide ursodesoxycholique. | |
| FR2519253A1 (fr) | Procede pour isoler des composes a effet laxatif du sene medicinal, ces composes et leurs utilisations therapeutiques | |
| JPH05112488A (ja) | １０−ヒドロキシ−δ−２−デセン酸の製法 | |
| CH401088A (fr) | Procédé d'obtention du 1-rhamnoside de 6-méthyl-1,3,8-trihydroxyanthraquinone par extraction conditionnée de Rhamnacées | |
| BE430985A (enrdf_load_stackoverflow) | ||
| BE515118A (enrdf_load_stackoverflow) | ||
| BE525749A (enrdf_load_stackoverflow) | ||
| CH394488A (fr) | Procédé de préparation d'antigènes cellulaires | |
| BE521899A (enrdf_load_stackoverflow) | ||
| CH285944A (fr) | Procédé de préparation de sels purs d'antibiotiques de caractère basique, notamment d'antibiotiques du type de la streptomycine. | |
| BE480678A (enrdf_load_stackoverflow) | ||
| BE470863A (enrdf_load_stackoverflow) | ||
| BE416160A (enrdf_load_stackoverflow) | ||
| CH286676A (fr) | Procédé de préparation de la procäine-pénicilline. | |
| BE572199A (enrdf_load_stackoverflow) | ||
| BE476705A (enrdf_load_stackoverflow) | ||
| BE505856A (enrdf_load_stackoverflow) |